Oxford Biosystems
  • News

    News from Oxford BioSystems

    News from Oxford BioSystems
Chronic kidney disease (CKD) affects not only kidney function but also bone metabolism, creating a complex network of hormonal and mineral imbalances. These changes can lead to chronic kidney disease–mineral and bone disorder (CKD-MBD), a condition associated with bone abnormalities, vascular calcification and increased cardiovascular risk.
Read More
At Oxford BioSystems we’ve observed that biomedical research increasingly relies on analysing multiple biomarkers at once. Whether studying immune responses, nutritional status, or complex disease pathways, running multiple single-analyte ELISAs can quickly become costly, time-consuming and sample-intensive.
Read More
Children and adolescents living with type 1 diabetes (T1D) frequently experience challenges related to bone health. Studies indicate that young people with T1D often have reduced bone mineral density, alongside changes in bone microarchitecture and lower rates of bone turnover when compared with healthy peers.
Read More
Victoria Munro, Programme Manager at Oxford BioSystems, has been part of the business for 15 years. With a PhD in Biological Sciences and a career spanning the clinical and life sciences sectors, she brings a clear, evidence-based mindset to her role.
Read More
We are delighted to announce that Oxford BioSystems will be returning to the 15th Annual Mellanby Research Centre Meeting on 6th March 2026 in Sheffield.
Read More
Biomedical Scientist recently published ‘A preventative approach for Alzheimer’s’, which explores the first study evaluating the impact of obesity on Alzheimer’s blood biomarkers.
Read More
The official flower for a 25th anniversary is the iris, and it is also recognized as the birth flower for the month of February. Irises represent wisdom, hope, and trust.
Read More
The interleukin-2 receptor (IL-2R), also known as CD25, is a transmembrane protein, which is up-regulated on activated T-cells, and shed into serum as soluble IL-2R...
Read More
As laboratories strive to produce faster, more consistent and publication-quality immunoassay data, the need for advanced imaging technology has never been greater.
Read More
25Jul

G6PD Deficiency

Oxford Biosystems | 25 Jul, 2024 | Haematology |
Why is a rapid G6PD test of interest? Glucose-6-phosphate dehydrogenase (G6PD) is a housekeeping enzyme that plays a vital role in the prevention of cellular damage...
Read More
Page 1 of 2 FirstPrevious [1]

Categories

Oxford BioSystems

184B Park Drive Milton Park Abingdon Oxon OX14 4SE

Oxford Biosystems has pledged to be an Antibiotic Guardian

members of

BIVDA Member Logo IBMS Company Member